Bangun Kosambi Sukses Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Bangun Kosambi Sukses Tbk. trades at Rp3,500 (market cap 19.5T, 1.85M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Bangun Kosambi Sukses Tbk. is the larger of the two by market cap, and Bangun Kosambi Sukses Tbk. is more actively traded (1.85M versus 613K). Which is the better fit depends on your goals.
| CBDK | TSPC | |
|---|---|---|
Market Cap | 19.5T | 11.18T |
Volume | 1.85M | 613K |
Lot | 18.52K | 6.13K |
Turnover | 6.5B | 1.54B |
Average Price | 3,512.14 | 2,511.52 |
Value | 6.5B | 1.54B |
Indicative Equilibrium Price | 3,500 | 2,520 |
Indicative Equilibrium Volume | 522 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bangun Kosambi Sukses Tbk (the Company) was established based on Notarial Deed No. 01 of Djedjem Widjaja, S.H., M.H., dated 3 April 2000. The Company commenced its commercial operations in 2020. The Company is controlled by its immediate parent company, PT Pantai Indah Kapuk Dua Tbk, domiciled in Jakarta and its ultimate parent companies are PT Agung Sedayu and PT Tunas Mekar Jaya, domiciled in Jakarta.
Read more on CBDK →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →